BILLS-105hr3925ih.pdf

year 1996 annual 19 year later than October 1 preceding fiscal years later than 30 days MAY 21, 1998 one year 42 U.S.C. 1396r–8(b)(3)(A 42 U.S.C. 1396r 15 1999 later than July 1, 1999 Between 1981 and 1998 14 1986 42 U.S.C. 1395b 1996 October 1, 1999 October 1, 2003 later than January 1 of each year 1998

the ‘‘Commission SESSION H. R. 3925

the United States Canada United States Mexico the United States of America Australia Georgia Japan

American Americans

SEC Senate Commission the Committee on Commerce United Health and Human Services Congress the Federal Government the Committee on Finance House Treasury the Internal Revenue Code THE HOUSE OF REPRESENTATIVES Public Health Service Internal Revenue Service Corporation Source the European Union Federal House of Representatives medicaid Board State ULE the Prescription Drug Price Monitoring Commission Statistics of Income the Committee on Ways 25 House of Representa- the Medicare Payment Advisory a)(4 Ways and Means of the Prescription Drug Price Monitoring Commission the Special Committee medicare the Internal Revenue Service the Social Security Act the Special Committee on Aging of the United States Veterans Affairs Ways and Means APPOINTMENT.—The Commission the Department of Defense DEFAZIO European Union

STARK LEWIS BOUCHER BERRY XVIII CLEMENT FURSE ALLEN DINGELL

prescription prescription drug prescription drugs drugs prices excessive price drug elderly scription inflation recommend industry products commission